News
Apr 24, 2023
CARLSBAD, Calif., April 24, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Incexternal link, opens in a new tab. (Nasdaq: IONSexternal link, opens in a new tab) today…
Feb 22, 2023
April Johnson Stearns, Founder, and Editor-in-Chief, of WILDFIRE Magazine is leading a workshop for anyone interested in using their voice to advocate for…
Aug 03, 2022
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the APOLLO-B Phase 3 study of patisiran, an…
Jul 12, 2021
Novo Nordisk has struck a $1.2 billion deal to buy Prothena’s ATTR amyloidosis program, which was stalled by the pandemic last year.The deal will see Novo pay $100…
Jun 20, 2020
AbstractTransthyretin amyloid cardiomyopathy (ATTR-CM) results in a restrictive cardiomyopathy caused by extracellular deposition of transthyretin, normally…
Apr 17, 2020
The American Society of Nuclear Cardiologyexternal link, opens in a new tab designates this live activity for a maximum of 4 CME Credits(tm). Physicians should…
Mar 26, 2020
This discussion was recorded on March 24, 2020. American Society of Nuclear Cardiology (ASNC) leaders and global leaders in China and Singapore addressed the…
Feb 22, 2020
The Amyloidosis Foundationexternal link, opens in a new tab is proud to be a partner at this event, Amyloidosis: A Disease Now at the Forefront of Practice Latest…
ardiac amyloidosis is characterized by deposition of misfolded protein in the myocardium causing mainly heart failure symptoms with preserved left ventricular…